futureTEKnow Company Profile

Company

Deep Genomics

Deep Genomics is in the field of drug discovery and development using AI to identify novel targets for therapeutic intervention.

Headquarters

Ontario, Canada

Year Founded

2014

About Us

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.

Trending Companies

Latest Articles

futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.

© 2026 All Rights Reserved.